Literature cited
N. V. Khromov-Borisov and M. Michelson (N. V. Khromov-Borisov et al.), Pharm. Rev.,18, 1051 (1966).
S. E. Severin, P. L. Vul'fson, and L. L. Tradafilova, Dokl. Akad. Nauk SSSR,145, 215 (1962).
S. E. Severin, in: Contemporary Problems of Peptide Chemistry [in Russian], Moscow (1969), pp. 148–156.
A. H. Beckett, Ann. N. Y. Acad. Sci.,144, 675 (1967).
G. Bertaccini and T. Vitali, J. Pharm. Pharmacol.,16, 441 (1964).
N. V. Khromov-Borisov, in: Ergebnisse der experimentellen Medizin, Vol. 17, Part 1, Berlin (1974), pp. 117–125.
N. V. Khromov-Borisov, M. L. Indenbom, and A. F. Danilov, Khim. Farm. Zh., No. 9, 3 (1971).
A. F. Danilov, M. L. Indenbom, and N. V. Khromov-Borisov, Farmakol. Toksikol., No. 2, 160 (1972).
N. V. Khromov-Borisov, M. L. Indenbom, A. F. Danilov, et al., Khim. Farm. Zh., No. 6, 5 (1973).
D. Bovet, F. Bovet-Nitti, and G. B. Marini-Bettolo, in: Curare and Curare-Like Agents, (ed. by D. Bovet et al.), Am. Elsevier, New York-Amsterdam (1959), p. 263.
A. F. Danilov, “Structure of the choline receptors of skeletal muscles and the mechanism of action of myorelaxants,” Doctoral Dissertation, Leningrad (1968).
N. V. Khromov-Borisov, M. L. Indenbom, and A. F. Danilov, Khim. Farm, Zh., No. 3, 9 (1974).
N. V. Khromov-Borisov, A. F. Danilov, M. L. Indenbom, et al., Farmakol. Toksikol., No. 6, 683 (1975).
F. Sadritdinov, Farmakol. Toksikol., No. 3, 327 (1962).
D. A. Kharkevich and A. P. Skoldinov, Dokl. Akad. Nauk SSSR,198, 985 (1971).
N. T. Pryanishnikova, A. P. Drozhzhin, and M. M. Fel'dshtein, Farmakol. Toksikol., No. 4, 418 (1974).
W. R. Buckett, S. L. Hewett, D. S. Savage, A. F. Cameron, G. Ferguson, et al., J. Med. Chem.,16, 1116 (1973).
J. J. Savarese and R. J. Kitz, Acta Anaesthesiol. Scand.,17, Suppl. 15, 34 (1973).
D. S. Savage, A. F. Cameron, G. Ferguson, et al., J. Chem. Soc. (B), No. 3, 410 (1971).
N. V. Khromov-Borisov, Farmakol. Toksikol., No. 5, 583 (1972).
W. D. M. Paton and W. L. M. Perry, J. Physiol. London,119, 43 (1953).
F. G. Canepa, P. Pauling, and H. Sörum, Nature,210, 907 (1966).
C. C. J. Culvenor and N. S. Ham, Chem. Commun., 537 (1966).
A. Albert, Selective Toxicity: The Physicochemical Basis of Therapy, Halsted Press, New York-London (1973), pp. 456–457.
P. D. Armstrong and J. G. Cannon, Nature,220, 65 (1968); J. Med. Chem.,13, 1037 (1970).
C. Y. Chiou, J. P. Long, J. G. Cannon, et al., J. Pharmacol. Exp. Ther.,166, 243 (1969).
C. Chothia and P. Pauling, Nature,226, 541 (1970).
D. L. Beveridge and R. J. Randa, J. Am. Chem. Soc.,93, 3759 (1971).
D. Ajo, M. Rossa, A. Damiani, et al., J. Theor. Biol.,34, 15 (1972).
M. Froimowitz and P. I. Gans, J. Am. Chem. Soc.,94, 8020 (1972).
I. Ya. Aleksandrova, V. L. Gol'dfarb, N. V. Khromov-Borisov, et al., Zh. Organ. Khim., No. 5, 1109 (1976).
Yu. S. Borodkin, Antifeine [in Russian], Moscow (1966).
V. V. Bul'on and É. A. Migas, Farmakol. Toksikol., No. 5, 710 (1974).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, No. 11, pp. 5–14, November, 1976.
Rights and permissions
About this article
Cite this article
Khromov-Borisov, N.V. Significance of the conformation during the interaction of biologically active molecules with receptors. Pharm Chem J 10, 1434–1442 (1976). https://doi.org/10.1007/BF00760372
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00760372